Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of Torasemide-PR vs Torasemide-IR vs Furosemide-IR in Compensated Heart Failure
NCT01549158Phase 4Terminated
- Sponsor
- Ferrer
- Start
- Feb 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of torasemide in heart failure (HF) (3 arms), sponsored by Ferrer. Primary endpoint: Efficiency of sodium excretion at 24 hours. Started Feb 2012; status: terminated.
02
Drugs
torasemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01549158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549158.